-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ShmL+ngEoGcnSQrgiQZwMB3JXvG5QYoG/sd5tnj1vLLWwFwAQ+ZlSzpoqm6EGksx DVszh67jur2gHhNo+N6mRg== 0001179110-08-014133.txt : 20080725 0001179110-08-014133.hdr.sgml : 20080725 20080725211225 ACCESSION NUMBER: 0001179110-08-014133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080724 FILED AS OF DATE: 20080725 DATE AS OF CHANGE: 20080725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BISCHOFBERGER NORBERT W CENTRAL INDEX KEY: 0001190273 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 08971830 BUSINESS ADDRESS: BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR STREET 2: C/O GILEAD SCIENCES, INC. CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgar.xml FORM 4 - X0303 4 2008-07-24 0 0000882095 GILEAD SCIENCES INC GILD 0001190273 BISCHOFBERGER NORBERT W GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 0 1 0 0 EVP, R&D and CSO Common Stock 2008-07-24 4 M 0 150000 15.2650 A 1226525 D Common Stock 2008-07-24 4 S 0 150000 52.0702 D 1076525 D Common Stock 2008-07-24 4 S 0 30000 52.1452 D 89394 I by Trust Common Stock 1600 I By Daughter Common Stock 1600 I By Son Non-Qualified Stock Option (right to buy) 15.2650 2008-07-24 4 M 0 150000 0 D 2014-01-28 Common Stock 150000 303452 D Amount of securities beneficially owned following the reported transaction includes 792 shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan on June 30, 2008. Sale prices reported for the transactions reported here range from $51.94 to $52.37. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $52.00 to $52.38. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. The options have a five year vesting schedule. 20% of the options vested on 1/28/2005, the first anniversary date of the grant. The balance vests 5% every three months thereafter until fully vested on 1/28/2009. /s/ Norbert W. Bischofberger 2008-07-24 -----END PRIVACY-ENHANCED MESSAGE-----